bpc-157 fda approval status unapproved new drug warning peptide safety risks The FDA has issued clear signals BPC-157 FDA 2026: – Vincent Pedre, MD FMCP |

It did not produce the magnitude of weight loss we now consider transformative, which is why it never became a mainstream drug

Safety, Tolerability and Pharmacokinetics of PL 14736, a Novel Agent for Treatment of Ulcerative Colitis, in Healthy Male Volunteers

In obesity, NNMT activity is unusually high in fat cells, which means a lot of nicotinamide gets thrown out before it can be turned into NAD+

But even a pure form of a drug that hasnt been through rigorous testing isnt necessarily a safe one

Finnrick independently confirms 99%+ purity across all tested compounds

It's worth noting that MIC B12 injections can be administered either intramuscularly (directly into the muscle) or subcutaneously (into the tissue layer between the skin and muscle)